These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 8033430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ, Balthasar JP.
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F, Balthasar JP.
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [Abstract] [Full Text] [Related]

  • 4. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS, Badakere SS.
    J Postgrad Med; 1996 Apr; 42(2):46-9. PubMed ID: 9715299
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR, Song S, Siragam V, Lazarus AH.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5 Suppl):710-3. PubMed ID: 16933274
    [Abstract] [Full Text] [Related]

  • 6. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy.
    Pogliani EM, Della Volpe A, Casaroli I, Maffe PF, Corneo G.
    Allergol Immunopathol (Madr); 1991 Oct 15; 19(3):113-6. PubMed ID: 1799168
    [Abstract] [Full Text] [Related]

  • 7. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R, Lemieux R, Tremblay T, St-Amour I.
    Br J Haematol; 2004 Oct 15; 127(1):90-6. PubMed ID: 15384982
    [Abstract] [Full Text] [Related]

  • 8. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
    Kuwana M, Kaburaki J, Ikeda Y.
    J Clin Invest; 1998 Oct 01; 102(7):1393-402. PubMed ID: 9769332
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.
    Andersson PO, Wadenvik H.
    Expert Rev Mol Med; 2004 Nov 09; 6(24):1-17. PubMed ID: 15538954
    [Abstract] [Full Text] [Related]

  • 11. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
    Kosugi S, Tomiyama Y, Shiraga M, Kashiwagi H, Mizutani H, Kanakura Y, Kurata Y, Matsuzawa Y.
    Thromb Haemost; 1996 Feb 09; 75(2):339-45. PubMed ID: 8815587
    [Abstract] [Full Text] [Related]

  • 12. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F.
    Eur J Haematol Suppl; 2008 Feb 09; (69):19-26. PubMed ID: 18211569
    [Abstract] [Full Text] [Related]

  • 13. Novel approaches to refractory immune thrombocytopenic purpura.
    Bussel JB.
    Blood Rev; 2002 Mar 09; 16(1):31-6. PubMed ID: 11913991
    [Abstract] [Full Text] [Related]

  • 14. Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment.
    Levy Y, Sherer Y, Ahmed A, Fabbrizzi F, Terryberry J, Shen GQ, Peter JB, Shoenfeld Y.
    Nat Immun; 1998 Mar 09; 16(5-6):207-14. PubMed ID: 11061589
    [Abstract] [Full Text] [Related]

  • 15. Studies of platelet-bound and serum platelet-bindable immunoglobulins in dogs with idiopathic thrombocytopenic purpura.
    Lewis DC, Meyers KM.
    Exp Hematol; 1996 May 09; 24(6):696-701. PubMed ID: 8635525
    [Abstract] [Full Text] [Related]

  • 16. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V, Brinc D, Crow AR, Song S, Freedman J, Lazarus AH.
    J Clin Invest; 2005 Jan 09; 115(1):155-60. PubMed ID: 15630455
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
    McMillan R.
    Hematol Oncol Clin North Am; 2009 Dec 09; 23(6):1163-75. PubMed ID: 19932426
    [Abstract] [Full Text] [Related]

  • 18. [Immune thrombocytopenic purpura (ITP)].
    Udvardy M.
    Orv Hetil; 2001 Dec 09; 142(49):2723-30. PubMed ID: 11883173
    [Abstract] [Full Text] [Related]

  • 19. Anti-alphavbeta3 antibodies in chronic immune thrombocytopenic purpura.
    Kosugi S, Tomiyama Y, Honda S, Kashiwagi H, Shiraga M, Tadokoro S, Kiyoi T, Kurata Y, Matsuzawa Y.
    Thromb Haemost; 2001 Jan 09; 85(1):36-41. PubMed ID: 11204584
    [Abstract] [Full Text] [Related]

  • 20. Acute inflammatory sensorimotor polyradiculoneuropathy associated with immune thrombocytopenic purpura.
    Sato N, Kamata T, Akiyama N, Kuwana M, Kanda T.
    J Intern Med; 2005 May 09; 257(5):473-7. PubMed ID: 15836665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.